Niagen Bioscience Inc
NAGE
Rank in Stocks
#17459
Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus... Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.
Share Price
$2.07
Last synced: 2026-11-13
Market Cap
$163.44M
Change (1 day)
-3.05%
Change (1 year)
-69.23%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Niagen Bioscience Inc (NAGE)
Category
Healthcare
Operating Margin for Niagen Bioscience Inc (NAGE)
Operating Margin as of November 2026 TTM: 2.28%
According to Niagen Bioscience Inc's latest financial reports, its current operating margin (TTM) is 2.28%. At the end of 2025 the company had an operating margin of 11.05%.
Operating Margin history for Niagen Bioscience Inc from 2007 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 2.28% | -79.37% |
| 2025 | 11.05% | 42.40% |
| 2024 | 7.76% | -215.82% |
| 2023 | -6.70% | -74.08% |
| 2022 | -25.85% | -35.60% |
| 2021 | -40.14% | 19.82% |
| 2020 | -33.50% | -50.46% |
| 2019 | -67.62% | -35.67% |
| 2018 | -105.12% | 36.08% |
| 2017 | -77.25% | 476.06% |
| 2016 | -13.41% | 16.10% |
| 2015 | -11.55% | -66.19% |
| 2014 | -34.16% | -20.87% |
| 2013 | -43.17% | -56.92% |
| 2012 | -100.22% | 3.38% |
| 2011 | -96.94% | 263.62% |
| 2010 | -26.66% | 72.56% |
| 2009 | -15.45% | -66.27% |
| 2008 | -45.80% | 0.00% |
| 2007 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -195.39% | -185.70% |
US
|
|
| 33.87% | -85.14% |
US
|
|
| -116.04% | -150.89% |
US
|
|
| 25.57% | -88.79% |
AU
|
|
| 31.23% | -86.30% |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Niagen Bioscience Inc's operating margin
What is Niagen Bioscience Inc's operating margin?
Niagen Bioscience Inc's operating margin is 2.28%, as of Nov 2026.
What was Niagen Bioscience Inc's operating margin in 2025?
In 2025, Niagen Bioscience Inc's operating margin was 11.05%, compared with 7.76% in 2024.
How has Niagen Bioscience Inc's operating margin changed since 2020?
From 2020 to 2025, Niagen Bioscience Inc's operating margin was highest in 2025 (11.05%) and lowest in 2021 (-40.14%).
How does Niagen Bioscience Inc's operating margin compare with similar companies?
Niagen Bioscience Inc's operating margin (2.28%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.